Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Clinical Trial ID NCT00003782

PubWeight™ 8.18‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00003782

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 2010 5.17
2 Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. J Clin Oncol 2011 1.56
3 Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. Cancer Epidemiol Biomarkers Prev 2015 0.81
4 Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy. J Natl Cancer Inst 2015 0.75
Next 100